Eli Lilly and Co (NYSE:LLY)
| 310.51 Delayed Data As of Aug 16 |  -3.43 / -1.09%Today’s Change | 220.20 Today|||52-Week Range 335.33 | +12.41% Year-to-Date |
LLY Regular Dividend: LLY began trading ex-dividend on 08/12/22. A $0.98 dividend will be paid to shareholders of record as of 08/15/22.
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 313.94 |
| Today’s open | 314.84 |
| Day’s range | 309.62 - 314.84 |
| Volume | 2,247,979 |
| Average volume (3 months) | 2,880,216 |
| Market cap | $292.7B |
Data as of 4:00pm ET, 08/16/2022
Growth & Valuation
| Earnings growth (last year) | -9.81% |
| Earnings growth (this year) | -1.79% |
| Earnings growth (next 5 years) | +20.80% |
| Revenue growth (last year) | +15.40% |
| P/E ratio | 49.5 |
| Price/Sales | 8.89 |
| Price/Book | 32.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.13 | +0.26% |
| ABBVAbbVie | +0.26 | +0.18% |
| MRKMerck | -0.03 | -0.03% |
| AZNAstraZeneca | -0.07 | -0.10% |
Data as of 4:00pm ET, 08/16/2022
Financials
| Next reporting date | November 1, 2022 |
| EPS forecast (this quarter) | $1.91 |
| Annual revenue (last year) | $28.3B |
| Annual profit (last year) | $5.6B |
| Net profit margin | 19.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
